Characterization of glycometabolism and tumor immune microenvironment for predicting clinical outcomes in gastric cancer
Open Access
- 16 February 2023
- Vol. 26 (3) , 106214
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (U20A20371)
- National High-tech Research and Development Program (2014AA020603)
- Peking University (81802471)
- Peking University (81972758)
- Peking University (81872502)
- Peking University (BMU2019LCKXJ011)
This publication has 34 references indexed in Scilit:
- Inferring tumour purity and stromal and immune cell admixture from expression dataNature Communications, 2013
- Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cellsNucleic Acids Research, 2012
- Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not AnticipateCancer Cell, 2012
- Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trialThe Lancet, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Understanding the Warburg Effect: The Metabolic Requirements of Cell ProliferationScience, 2009
- Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal CancerNew England Journal of Medicine, 2006
- X-TileClinical Cancer Research, 2004
- Influence of low pH on cytotoxicity of paclitaxel, mitoxantrone and topotecanBritish Journal of Cancer, 1997
- On the Origin of Cancer CellsScience, 1956